Actively Recruiting
Neuromodulation and Neuroimaging in Older Children With Mild Traumatic Brain Injury
Led by State University of New York at Buffalo · Updated on 2026-02-03
10
Participants Needed
1
Research Sites
171 weeks
Total Duration
On this page
Sponsors
S
State University of New York at Buffalo
Lead Sponsor
N
National Center for Advancing Translational Sciences (NCATS)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Mild traumatic brain injury (mTBI) often causes persistent motor and cognitive deficits in children resulting in functional limitations. We are testing a brain stimulation method along with evaluating objective tools to help record and restore communication among affected brain areas, which will facilitate recovery in youth after mTBI.
CONDITIONS
Official Title
Neuromodulation and Neuroimaging in Older Children With Mild Traumatic Brain Injury
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ages 10 to 15 years at enrollment
- For experimental group: enrolled at least 6 weeks after mild traumatic brain injury (mTBI)
- Exhibiting post-concussive symptoms such as difficulty planning, sequencing, and executing motor actions
- Sustained a mild traumatic brain injury or concussion within the past 12 months
- Parent and child are proficient in English
- For healthy controls: ages 10 to 15 years
- For healthy controls: no concussion history
- Parent and child are proficient in English
You will not qualify if you...
- Loss of consciousness longer than 30 minutes
- Post-traumatic amnesia longer than 24 hours
- Intracranial findings on clinical imaging
- History of developmental delay
- History of learning disability or ADHD
- Unhealed lower or upper limb injury
- History of seizures
- Severe skin problems at electrode sites
- Metal implants, shrapnel, or electronic implants in head, neck, or body
- Craniotomy or surgery within the past 6 weeks
- Claustrophobia
- Eye injury involving metal without clearance
- Pregnancy reported by parent/guardian (for females 14 and older, additional screening at MRI visits)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ghazala Saleem
Buffalo, New York, United States, 14214
Actively Recruiting
Research Team
G
Ghazala Saleem, EdD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here